-
1.
公开(公告)号:US20230220361A1
公开(公告)日:2023-07-13
申请号:US17817781
申请日:2022-08-05
发明人: Rafal KAMINSKI , Tricia BURDO
CPC分类号: C12N9/22 , C12N15/86 , A61P31/18 , C12N2310/20
摘要: Migration of HIV-1 infected monocytes across the endothelial barrier plays an essential role in establishing and maintenance of viral reservoir in the brain and leads to neuroinflammation, neuronal damage, and subsequent HIV-induced central nervous system (CNS) dysfunction. These processes continue despite antiretroviral therapy (ART) due to limited pharmacological permeability of the blood-brain barrier, the presence of residual viral replication, and the reactivation of latent viruses. Compositions comprising Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)-associated endonucleases targeted to activated leukocytes cell adhesion molecule (ALCAM/CD166), chemotactic recruitment (CCR2/5), adhesion to the endothelium (ALCAM) and junctional diapedesis (JAM-A) achieves maximum repression of leukocyte transmigration and block of the spread of the virus to different tissues and organs.
-
公开(公告)号:US20240336939A1
公开(公告)日:2024-10-10
申请号:US18566446
申请日:2022-06-02
发明人: Kamel KHALILI , Rafal KAMINSKI
CPC分类号: C12N15/907 , C12N9/22 , C12N15/11
摘要: Compositions include CRISPR-associated endonuclease, and one or more isolated nucleic acid sequences encoding gRNAs, wherein each gRNA is complementary to a target sequence in a retroviral genome. At least one endonuclease targets a Mannosyl Oligosaccharide Glucosidase (MOGS).
-
公开(公告)号:US20240261436A1
公开(公告)日:2024-08-08
申请号:US18566468
申请日:2022-06-02
发明人: Kamel KHALILI , Rafal KAMINSKI
IPC分类号: A61K48/00 , A61K31/4985 , A61K31/505 , A61K31/52 , A61K31/7068 , A61P31/18 , C12N9/22 , C12N15/113
CPC分类号: A61K48/005 , A61K31/4985 , A61K31/505 , A61K31/52 , A61K31/7068 , A61P31/18 , C12N9/22 , C12N15/1132 , C12N15/1138 , C12N2310/20
摘要: Compositions for specifically cleaving target sequences in retroviruses include nucleic acids encoding a Clustered Regularly Interspace Short Palindromic Repeat (CRISPR) associated endonuclease and a guide RNA sequence complementary to a target sequence in a retrovirus and a receptor used by a retrovirus for infecting a cell. The CRISPR construct edits, for example, proviral HIV DNA, thereby eliminating the provirus from an infected cell and simultaneously edits a viral receptor, e.g. CCR5 preventing infection and reinfection of the host.
-
-